---
title: "Wegovy and Ozempic tied to dramatically lower cancer deaths"
date: 2025-11-12T12:59:27.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/11/251112011810.htm"
image: ""
excerpt: "GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users. Researchers suspect the drugs’ anti-inflammatory and metabolic effects contribute to improved outcomes. They’re now calling for clinical trials to test whether these findings reflect…"
---